Metraipolis › archive › dc_a4341ade687f

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma — Europe PMC PMID:42140948

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42140948
DOI
10.1038/s41467-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-02T05:38:07.444Z
SHA-256 of the archived text
f37260e48ee9258e1fa8611e838c51cf27a1985102fcefd9360121b4c58b0c7e
Stable URL of this page
https://metraipolis.com/documento/dc_a4341ade687f

How to cite

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma — Europe PMC PMID:42140948 — Europe PMC (en), https://europepmc.org/article/MED/42140948 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a4341ade687f (Metraipolis archive dc_a4341ade687f, sha256 f37260e48ee9258e1fa8611e838c51cf27a1985102fcefd9360121b4c58b0c7e)
BibTeX
@misc{dca4341ade687f,
  title = {A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma — Europe PMC PMID:42140948},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42140948},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a4341ade687f; sha256 f37260e48ee9258e1fa8611e838c51cf27a1985102fcefd9360121b4c58b0c7e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42140948. Agents can read the archived copy with the MCP tool read_document.